This brand name is authorized in United States
The drug HALOG contains one active pharmaceutical ingredient (API):
|
1
Halcinonide
UNII SI86V6QNEG - HALCINONIDE
|
|
Halcinonide is a topical corticosteroid. Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity is unclear. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| HALOG Ointment | FDA, National Drug Code (US) | MPI, US: SPL/Old |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 0003-0249, 10631-094, 10631-095, 10631-096 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
